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Abstract
Poliovirus is an enteric virus that rarely invades the human central nervous system (CNS). To identify barriers limiting
poliovirus spread from the periphery to CNS, we monitored trafficking of 10 marked viruses. After oral inoculation of
susceptible mice, poliovirus was present in peripheral neurons, including vagus and sciatic nerves. To model viral trafficking
in peripheral neurons, we intramuscularly injected mice with poliovirus, which follows a muscle–sciatic nerve–spinal cord–
brain route. Only 20% of the poliovirus population successfully moved from muscle to brain, and three barriers limiting viral
trafficking were identified. First, using light-sensitive viruses, we found limited viral replication in peripheral neurons.
Second, retrograde axonal transport of poliovirus in peripheral neurons was inefficient; however, the efficiency was
increased upon muscle damage, which also increased the transport efficiency of a non-viral neural tracer, wheat germ
agglutinin. Third, using susceptible interferon (IFN) a/b receptor knockout mice, we demonstrated that the IFN response
limited viral movement from the periphery to the brain. Surprisingly, the retrograde axonal transport barrier was equivalent
in strength to the IFN barrier. Illustrating the importance of barriers created by the IFN response and inefficient axonal
transport, IFN a/b receptor knockout mice with muscle damage permitted 80% of the viral population to access the brain,
and succumbed to disease three times faster than mice with intact barriers. These results suggest that multiple separate
barriers limit poliovirus trafficking from peripheral neurons to the CNS, possibly explaining the rare incidence of paralytic
poliomyelitis. This study identifies inefficient axonal transport as a substantial barrier to poliovirus trafficking in peripheral
neurons, which may limit CNS access for other viruses.
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Introduction
Many viruses are neurotropic, including West Nile virus, rabies
virus, alpha herpesviruses, and poliovirus. To gain access and
sustain infection in neurons, viruses must be able to efficiently
traffic in axons, which can be up to one meter long. Therefore,
viral trafficking in neurons requires an active transport system
[1,2]. Poliovirus is thought to enter neurons via receptor-mediated
endocytosis at the neuromuscular junction, followed by endocytic
transport from the nerve terminal to the cell body using the host
retrograde axonal transport system. Poliovirus and some herpes-
viruses are thought to hijack the host transport machinery via
Tctex-1, a component of the dynein light chain involved in
retrograde axonal transport [3,4].
Poliovirus is an enteric virus that rarely causes disease; however,
in the pre-vaccine era, ,1% of infected individuals developed
paralytic poliomyelitis due to viral invasion of the central nervous
system (CNS) and destruction of motor neurons. It is still unclear
whether poliovirus accesses the CNS via blood or neural routes,
but it has been shown that viremia is a prerequisite for CNS
invasion of humans and non-human primates [5,6]. In the 1990s,
mice expressing the human poliovirus receptor (CD155/PVR)
facilitated studies on poliovirus trafficking, although early models
were limited in scope due to resistance of the mice to oral infection
[7,8]. Ohka et al. recently developed PVR mice lacking the
interferon a/b receptor (IFNAR
2/2), an important component of
innate immunity, yielding PVR-IFNAR
2/2 mice that are orally
susceptible to poliovirus, and can be used to study viral
dissemination following the natural route of infection [9]. While
there is evidence for both blood and neural routes of poliovirus
dissemination [10], recent in vitro studies with cultured neurons,
and in vivo studies with PVR mice provide evidence for neural
trafficking to the CNS [7,11,12,13,14]. It is thought that viremic
blood seeds peripheral tissues, virus enters neurons of the
peripheral nervous system (PNS) that innervate peripheral tissues,
and virus traffics to the CNS using retrograde axonal transport.
Sciatic nerve models of poliovirus trafficking further support
CNS access via a neural route following peripheral infection,
because sciatic nerve transsection prevented disease in PVR mice
intramuscularly injected with poliovirus [12,14]. Similarly, sciatic
nerve transsection prevented retrograde axonal transport of
Theiler’s virus, a picornavirus related to poliovirus [15]. There-
fore, intramuscularly inoculated poliovirus traffics to the CNS in
neurons via the sciatic nerve. The sciatic nerve contains a bundle
of axons, each of which are single long cells that innervate the leg
muscle and relay information from the periphery to their cell
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requires viral uptake at the neuromuscular junction, active
transport within the long axons of the sciatic nerve, viral release
in the cell body within the spinal cord, and transport to the brain.
Here we use an artificial quasispecies to identify host barriers
limiting viral trafficking from the periphery to the CNS.
Previously, we uncovered a significant obstacle to viral trafficking
between muscle and brain that severely bottlenecked the viral
population [16,17], and here we identify multiple barriers that
contribute to this effect. By following viral population diversity, we
discovered three distinct barriers the virus encounters between the
periphery and the CNS: inefficient retrograde axonal transport in
peripheral neurons, the type I interferon response, and limited
viral replication in neurons of the PNS. To our knowledge, this is
the first time that efficiency of viral retrograde axonal transport
has been quantified, and identified as a major barrier limiting viral
access to the CNS.
Results
Poliovirus Trafficking from Peripheral Tissues to the CNS
is Limited by a Barrier Between the Peripheral and
Central Nervous Systems
Previously, using 10 marked viruses, we identified host barriers
that limit poliovirus trafficking from the gut to the CNS [16]. The
marked viruses contain groups of 4–8 silent point mutations
detectable by a hybridization-based assay, and constitute an
artificial quasispecies that can be used to monitor viral population
dynamics and identify host barriers that limit spread (Figure S1).
Using this assay and another artificial quasispecies assay, a barrier
was uncovered between a peripheral intramuscular injection site
and the brain [16,17]; however, the specific nature of this barrier
was unknown. The goal of this study was to legitimize viral
trafficking in PNS neurons as a potential route to the CNS
following oral inoculation, and to identify the specific host barriers
limiting viral trafficking from peripheral tissues to the CNS.
To determine whether poliovirus is present in peripheral
neurons following oral inoculation, orally susceptible PVR-
IFNAR
2/2 mice were orally inoculated with 2610
7 plaque
forming units (PFU) of the 10-virus mixture, tissues were harvested
upon disease onset, and viruses were detected by RT-PCR and the
viral diversity assay. We monitored poliovirus in two peripheral
nerves: the vagus nerve, which innervates multiple organs and is
part of the enteric nervous system, and the sciatic nerve, which
innervates leg muscle. Importantly, orally inoculated virus was
detected in the vagus nerve in 76% of mice and in the sciatic nerve
in 71% of mice (Figures 1A and S1).
Because poliovirus was detectable in sciatic nerve following oral
inoculation, we used the sciatic nerve as a relevant model
peripheral neuron to identify barriers contributing to the
bottleneck effect encountered by the virus between peripheral
organs and the CNS. PVR mice were intramuscularly inoculated
with 2610
7 PFU of the 10-virus mixture, tissues were harvested
upon disease onset, and viral population diversity was measured
with the viral diversity assay (Figure 1B). Of the 10 original input
viruses injected, we found an average of 9.5 viral pool members
present in muscle, 9.0 in sciatic nerve, 4.2 in spinal cord, and 1.8
in brain (Figure 1C). Similar results were obtained for tissues
harvested at an early time point, 30 hours post-infection (Figure
S2). A dramatic decrease in the number of viral population
members occurred between sciatic nerve and spinal cord,
suggesting that the viral population encountered a major barrier
between these sites. Importantly, viral titers from tissues do not
reflect the dramatic bottleneck encountered by the viral popula-
tion, because viral titers in spinal cord were 10,000-fold higher
than viral titers in sciatic nerve (Figure 2). Therefore, the viral
population was limited by a host barrier between the PNS and
CNS, but robust replication occurred post-barrier in the CNS.
These results uncovered barriers to viral trafficking that would
have been masked by analyzing titer alone, and suggest that a
significant barrier to viral CNS access occurs between the sciatic
nerve and spinal cord.
We devised three hypotheses to explain the barrier between
the PNS and CNS. First, the interferon response may limit
peripheral replication, reducing the amount of virus in the
periphery. Second, viral replication in peripheral neurons may
be minimal, limiting the number of viruses entering the CNS.
Third, retrograde axonal transport may be inefficient for
poliovirus. We tested each of these hypotheses to dissect the
mechanism of the PNS-to-CNS barrier.
Host Innate Immunity Contributes to the Barrier
To determine whether the type I interferon response contributes
to the sciatic-spinal cord barrier, we intramuscularly injected
2610
7 PFU of the 10-marked viruses into PVR-IFNAR
2/2 mice,
which lack the INFa/b receptor and are therefore deficient in
generating a type I interferon response. Upon disease onset, tissues
were harvested and viral population diversity was determined by
the viral diversity assay. As shown in Figure 1D, 2.5-fold more
viral pool members reached the brain in PVR-IFNAR
2/2 mice
than in PVR mice. Not surprisingly, viral titers were 4–17-fold
higher in PVR-IFNAR
2/2 mice than in PVR mice (Figure 2).
Interestingly, the largest viral titer difference between PVR and
PVR-IFNAR
2/2 mice was in the periphery, suggesting that the
interferon response limited viral trafficking by reducing replication
in peripheral tissue. In fact, the difference between PVR and
PVR-IFNAR
2/2 viral titers in the brain was minimal (less than
4-fold) and not statistically significant. One interpretation of these
results is that the type I interferon response exerts its effects in the
periphery and may contribute to the viral bottleneck by limiting
viral replication in peripheral tissues.
Author Summary
Neurotropic viruses, including herpesviruses, rabies virus,
and poliovirus, initiate infection in the periphery and can
move through peripheral neurons to reach the central
nervous system (CNS). Since peripheral neurons can be up
to one meter long, inefficient neural transport could
dramatically affect pathogenesis of neurotropic viruses. In
this study, we used a novel viral ‘‘bar-coding’’ assay to
quantify the efficiency of poliovirus transport from the
periphery to the CNS using a mouse model. Only 20% of
the poliovirus population successfully moved from the
periphery to the CNS. We discovered that transport of
poliovirus in peripheral neurons was very inefficient, and
the innate immune response also limited viral movement.
Surprisingly, the neural transport barrier was as strong as
the innate immune response barrier. Importantly, by
overcoming both the neural transport and innate immune
barriers, 80% of the poliovirus population successfully
moved from the periphery to the CNS, and mice
succumbed to disease three times faster than mice with
intact barriers. This study identifies inefficient neural
transport as a substantial barrier to viral movement in
peripheral neurons, which may limit CNS access for many
viruses.
Neurotropic Virus CNS Barriers
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Lack of replication in peripheral neurons could limit viral
diversity and contribute to inefficient trafficking to the CNS. To
quantify viral replication in vivo, we used light-sensitive polioviruses
[16]. Poliovirus propagated in the presence of neutral red dye
becomes light sensitive due to dye incorporation into the virion
[18,19,20]. Exposure to light inactivates neutral red-containing
virions, likely due to cross-linking of virion RNA; however, neutral
red viruses maintain viability if not exposed to light. Upon
uncoating, neutral red dye is diluted and viruses lose light
sensitivity. Therefore, viral replication can be quantified by
measuring the ratio of light-sensitive to light-insensitive virus.
We have adapted this assay for in vivo studies by injecting mice with
a pool of 10-marked neutral red viruses in the dark and comparing
light-exposed versus non light-exposed tissue virus samples by viral
titer analysis or the viral diversity assay.
First, we performed neutral red viral titer analysis to measure
the kinetics of viral replication in various tissues along the route to
the CNS. PVR mice were intramuscularly injected with 2610
7
PFU of the neutral red 10-virus pool, and muscle, sciatic nerve,
spinal cord, and brain were harvested in the dark (using a red
safety light) at 2, 6, 30 or 72 hours post infection (hpi). Tissues
were processed in the dark, and samples of light-exposed virus and
non-light exposed virus from each tissue were quantified by viral
titer assay. Figure 3 shows the total titer (i.e., dark titer; grey lines),
and the percent of virus that was replicated (i.e., light titer/dark
titer x100; black bars) at each time point for different tissues, and
the data indicate three key points. First, there was no evidence of
viral replication in any tissue at 2 hpi, but there was evidence of
viral replication in muscle, sciatic nerve and spinal cord at 6 hpi;
therefore, viral replication is relatively fast in vivo. Second, virus
was detectable in the spinal cord by 6 hpi, indicating that virus
moves very quickly from the muscle injection site to the CNS, in
agreement with previous work demonstrating viral movement by
fast retrograde axonal transport [12]. The virus found in the spinal
cord at 6 hpi was a mixture of replicated virus and non-replicated
virus from the inoculum. Third, while titers in spinal cord increase
over time by an average of 10,000-fold, titers in sciatic nerve
remain relatively constant. Similarly, viral titers in muscle remain
relatively constant despite viral replication at that site. Taken
together these results suggest a model where virus in muscle is
transported rapidly to the spinal cord via the sciatic nerve, but little
Figure 1. Identification of the barrier site between the periphery and CNS and the effect of type I interferon. (A) Detection of virus in
peripheral nerves after oral infection. PVR-IFNAR
2/2 mice were orally inoculated with 2610
7 PFU of poliovirus, tissues were harvested upon disease
onset, and the percentage of mice with detectable virus was quantified by RT-PCR. Mean with SEM from 13–14 mice is shown; more details are shown
in Figure S1. (B) A representative blot from the hybridization-based viral diversity assay. PVR mice were intramuscularly inoculated with 2610
7 PFU of
the 10-marked viruses, tissue were collected upon disease onset (ranging from 2 to 6 days post-inoculation, see Figure 6), and viral pool members
were detected with the viral diversity assay. Results from one representative mouse are shown. Viral population diversity in intramuscularly
inoculated (C) PVR mice or (D) PVR-IFNAR
2/2 mice. Mice were intramuscularly inoculated as in (B), and the number of pool members in each tissue for
each mouse is shown. Horizontal lines represent mean diversity for each tissue. Asterisks denote statistically significant reductions in viral population
diversity (Student’s t test, p,0.01). Viral population diversity in PVR-IFNAR
2/2 mice was significantly higher than in PVR mice across all tissues
(p,0.0001, 2 way ANOVA).
doi:10.1371/journal.ppat.1000791.g001
Neurotropic Virus CNS Barriers
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replication occurs in the CNS (spinal cord and brain).
To further test the idea that poliovirus does not replicate in the
sciatic nerve, we examined the replication status of individual viral
population members using neutral red-virus in conjunction with
the viral population diversity assay. PVR mice were intramuscu-
larly injected with 2610
7 PFU of the 10-marked neutral red virus
pool and tissues were harvested in the dark at 72 hpi, near the time
of disease onset. After processing tissues in the dark, we divided the
virus sample and exposed half to light and kept half in the dark.
Light exposed and non-light exposed virus samples were amplified
for a single cycle in HeLa cells to expand surviving viruses and
minimize the prevalence of inactivated viruses. Replication status
of tagged pool members was analyzed with the viral diversity assay
by comparing the signal of every viral pool member on the ‘‘light’’
vs. ‘‘dark’’ blots (see Figure 4A). Light-sensitive viruses were scored
as ‘non-replicated’, and light-insensitive viruses were scored as
‘replicated+non-replicated’ because they may contain a sub-
population of non-replicated viruses, which would be masked by
the signal from replicated viruses. ‘Non-replicated’ viruses consist
exclusively of viruses that did not replicate while in the mouse, due
to the absence of signal from the light-exposed sample. The results
from 10 PVR mice are summarized in Figure 4B, which shows the
overall number of viral pool members present in each tissue and
the proportion of those pool members that were non-replicated
viruses. In muscle, 30% of virus was non-replicated, in sciatic
Figure 2. Viral titers from intramuscularly inoculated PVR and
PVR-IFNAR
2/2 mice. Mice were inoculated with 2610
7 PFU, tissues
were harvested upon disease onset, and viral titers were determined by
plaque assay. Titers from PVR mice are depicted as closed circles, and
titers from PVR-IFNAR
2/2 mice are depicted as open squares, with
mean indicated by horizontal lines. The magnitude of the titer
difference between PVR and PVR-IFNAR
2/2 mice is indicated below
each tissue, and asterisks denote statistically significant differences
(p,0.0001, Student’s t test).
doi:10.1371/journal.ppat.1000791.g002
Figure 3. Viral replication kinetics. Mice were intramuscularly
inoculated with 2610
7 PFU of light-sensitive/neutral red poliovirus in
the dark, tissues were harvested at 2, 6, 30 and 72 hpi in the dark, and
virus was extracted in the dark. Half of the virus sample for each tissue
was exposed to light (inactivating non-replicated viruses, to quantify
replicated viruses), and half was maintained in the dark (to quantify all
viruses). Virus in light-exposed and non-exposed samples was
quantified by plaque assay. Total titer represents titer from non-light-
exposed sample and is expressed as PFU/tissue (grey lines). Therefore,
the grey lines represent titer from inoculum virus plus replicated virus.
The percent of replicated viruses was obtained by dividing the light-
exposed titer by the non-light-exposed titer for each individual sample
(black bars). Mean with SEM from 3–7 mice is shown.
doi:10.1371/journal.ppat.1000791.g003
Neurotropic Virus CNS Barriers
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based diversity assay for determining viral replication status. In the dark (using a red safety light; black star/grey boxes), the 10 marked viruses
containing neutral red dye were intramuscularly injected into the left gastrocnemius muscle of PVR or PVR-IFNAR
2/2 mice. At 72 hpi, tissues were
harvested and processed in the dark. The viral sample for each individual tissue was split, and half of the sample was exposed to light to inactivate
non-replicated virus (unfilled star/unfilled boxes), and the other half of the sample was kept in the dark. Both virus samples were amplified by a single
cycle of replication in HeLa cells to expand surviving virus and decrease the prevalence of light-inactivated virus. Total RNA was extracted, and the
tagged region of the viral genome was amplified by RT-PCR. DNA was then spotted on a membrane, and the viral diversity assay was performed.
Signal for each virus from the light-exposed and non-light exposed samples was compared for each tissue; sciatic nerve from a representative mouse
is shown as an example. Light-sensitive viruses were scored as ‘Non-replicated’ (in this case, viruses 3/4/5/6/7/8/9/10), and light-insensitive viruses
were scored as ‘Replicated+Non-replicated’ (in this case, viruses 2 and 11) because they may contain a sub-population of non-replicated viruses,
which would be masked by the signal from replicated viruses. Pooled results from each tissue for 10 PVR mice (B) and 5 PVR-IFNAR
2/2 mice (C) are
shown. Bars represent the mean diversity in each tissue, and the proportion of non-replicated virus is indicated (unfilled bar).
doi:10.1371/journal.ppat.1000791.g004
Neurotropic Virus CNS Barriers
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virus was non-replicated, and in brain, 0% of virus was non-
replicated. These results reinforce the idea that robust replication
occurs in CNS tissues, since 100% of brain viruses showed
evidence of viral replication. Interestingly, even at 72 hpi, 30% of
virus in muscle was non-replicated, indicating that this virus was
stable and not cleared over a three day period, but remained
viable since productive replication occurred in HeLa cells after
tissue harvest. In sciatic nerve, the majority of viruses (64%) were
non-replicated. Importantly, every single potentially replicated
virus in sciatic nerve was also replicated in muscle (28/28),
implying that ‘‘replicated’’ virus in sciatic nerve had undergone
replication in muscle prior to sciatic nerve entry. Because the
majority of viruses in sciatic nerve were non-replicated, and the
minority of light-insensitive/replicated viruses had undergone
replication in muscle, it is likely that poliovirus does not replicate
in axons of the sciatic nerve. To test whether the interferon
response limits viral replication, we repeated the experiment using
PVR-IFNAR
2/2 mice. Not surprisingly, we observed high
percentages of replicated virus in all tissues (Figure 4C). These
data, in conjunction with titer data from PVR-IFNAR
2/2 mice
(Figure 2B), imply that in the absence of the interferon response,
viral replication in muscle was so robust that nearly all viruses
replicated prior to entering the PNS. Taken together, these results
suggest that poliovirus does not replicate in axons of peripheral
neurons, rather, virus moves quickly from the peripheral injection
site to the CNS, and once in the CNS, undergoes robust
replication.
Retrograde Axonal Transport of Poliovirus is Inefficient in
Peripheral Neurons
Our data support previous work demonstrating that retrograde
axonal transport of poliovirus is fast [4,12,21]; however, the
efficiency of viral axonal transport has never been quantified. To
determine whether inefficient retrograde axonal transport con-
tributes to the barrier observed between sciatic nerve and spinal
cord, we monitored viral population diversity during viral
ascension of the sciatic nerve by harvesting segments of the nerve.
PVR mice were intramuscularly injected with 2610
7 PFU of the
10-marked virus pool and viral diversity was quantified in the
peripheral injection site (muscle), in three sections of the sciatic
nerve (lower, middle, upper), in spinal cord, and in brain. As
shown in Figure 5A (black bars), the lower section of the sciatic
nerve contained an average of 8.3 pool members, middle sciatic
contained 4.9 pool members, and upper sciatic contained 2.3 pool
members. Therefore, the entire barrier between the sciatic nerve
and spinal cord was due to loss of viral population members
between the lower sciatic nerve and upper sciatic nerve. Poliovirus
entry into the sciatic nerve at the neuromuscular junction was
efficient, since 87% of pool members present in muscle were
present in lower sciatic nerve; however, retrograde axonal
transport was inefficient, since only 28% of pool members were
successfully transported from lower sciatic nerve to upper sciatic
nerve.
Muscle Damage Increases Retrograde Axonal Transport
and Poliovirus Trafficking to the CNS
While limited population diversity in the upper sciatic nerve
suggests inefficient transport as a potential barrier to poliovirus
trafficking, to formally demonstrate that transport inefficiency is
the barrier, we determined whether increasing the efficiency of
retrograde axonal transport would increase poliovirus population
diversity in the CNS. Muscle damage via needle sticks is thought to
enhance access to the CNS because Gromeier and Wimmer
demonstrated enhanced poliovirus disease in mice subjected to
needle sticks following intravenous inoculation [21]. To test
whether needle sticks increase the efficiency of poliovirus retro-
grade axonal transport, PVR mice were intramuscularly injected
Figure 5. Quantification of retrograde axonal transport efficiency. (A) Efficiency of poliovirus transport and the effects of type I interferon
and muscle damage. PVR and PVR-IFNAR
2/2 mice were intramuscularly inoculated with 2610
7 PFU of the ten marked viruses, and were treated with
or without needle sticks twice per day to induce muscle damage. Tissues were harvested at disease onset, and viral diversity was quantified. PVR
mice, solid black bars; PVR mice with needle sticks, white hatched bars; PVR-IFNAR
2/2 mice, grey bars; PVR-IFNAR
2/2 mice with needle sticks, grey
hatched bars. Results are expressed as mean with SEM, representing 4-13 mice per group. Statistically significant differences between groups are
described in the text. (B) Efficiency of wheat germ agglutinin (WGA) transport and the effects of muscle damage. PVR mice were intramuscularly
injected with 5 mg of WGA and treated with or without needle sticks. Tissues were harvested at 6 hours post-injection, and were processed for ‘‘dot-
blot’’ protein immunoblot analysis. A WGA immunoblot, representative of four experiments, is shown under densitometry quantification (arbitrary
units). Signal was normalized to sciatic nerve tissue from PVR mice not injected with WGA (denoted DWGA). Total WGA signal in the sciatic nerve
represented approximately 1% of the WGA signal in muscle (data not shown).
doi:10.1371/journal.ppat.1000791.g005
Neurotropic Virus CNS Barriers
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twice per day to induce muscle damage. Upon disease onset,
tissues were harvested and the viral population diversity assay was
performed (Figure 5). In mice that received needle sticks, the brain
contained an average of 6.4 pool members, 3-fold more virus than
untreated mice, suggesting that muscle damage increased
poliovirus transport to the CNS (p,0.01, Students t test).
To verify that the muscle damage-mediated enhancement of
poliovirus trafficking was due to increased efficiency of retrograde
axonal transport, we monitored trafficking of a non-viral protein,
wheat germ agglutinin (WGA), which is commonly used as a
neural tracer [22,23]. PVR mice were intramuscularly injected
with 5 mg WGA, and treated with or without needle sticks. Tissues
were harvested at 6 hours post injection, and WGA was quantified
by immunoblotting (Figure 5B). In support of the idea that muscle
damage increased retrograde axonal transport, WGA signal in
middle and upper sciatic nerve was .3-fold higher in mice given
needle sticks compared with untreated mice. Interestingly, the
combined total of WGA signal for all sciatic nerve segments was
nearly identical in both treatment groups, suggesting that WGA
uptake at the neuromuscular junction was comparable; however,
WGA was transported more efficiently in mice with muscle
damage since more WGA was present in the middle and upper
sections of the sciatic nerve. Therefore, both poliovirus and WGA
have inefficient trafficking in the absence of muscle damage.
Taken together, these data suggested that retrograde axonal
transport of poliovirus is inefficient and constitutes a major barrier
to viral access to the CNS, but that efficiency of transport to the
CNS can be enhanced by muscle damage.
Overcoming Host Barriers Facilitates Efficient Viral
Trafficking to the CNS and Accelerates Disease Onset
Having identified inefficient retrograde axonal transport and
the interferon response as major barriers to viral trafficking, we
sought to determine whether eliminating both barriers would
facilitate efficient poliovirus trafficking to the CNS. PVR or PVR-
IFNAR
2/2 mice were intramuscularly injected with the 10-
marked virus pool in the presence or absence of needle sticks, and
population diversity was monitored. As expected, tissues from
PVR-IFNAR
2/2 mice contained significantly more population
members in brain (2.5-fold) than PVR mice (p,0.01, Students t
test) (Figure 5A). These numbers were comparable to the increased
diversity in brain (3-fold) observed in PVR mice given needle sticks
(p,0.001, Students t test). However, in PVR-IFNAR
2/2 mice
given needle sticks, sciatic nerve, spinal cord, and brain contained
nearly all ten viruses (average of 9.4 in upper sciatic, 9.0 in spinal
cord, and 8.0 pool members in brain), with significantly more viral
pool members trafficking to the brain than in PVR-IFNAR
2/2
mice or PVR mice given needle sticks (p,0.001, Students t test).
Our results suggest that the type I interferon response and
inefficient retrograde axonal transport may be separate barriers
and that overcoming both barriers facilitated efficient viral
trafficking to the CNS. This notion is further supported by the
time of disease onset for each treatment group. As shown in
Figure 6, using paralysis onset for 50% of mice per cohort as a
measure of pathogenesis, untreated PVR mice developed disease
on day 4.5 post infection, PVR mice given needle sticks and
untreated PVR-IFNAR
2/2 mice developed disease on day 3 post
infection, and PVR-IFNAR
2/2 mice given needle sticks devel-
oped disease on day 1.5 post infection. Therefore, overcoming one
of the two barriers increased pathogenesis, as disease onset was
1.5-fold faster than mice with both barriers intact. Furthermore,
eliminating two barriers dramatically enhanced pathogenesis,
as disease onset was 3-fold faster than in untreated mice. Taken
together, our results indicated that the type I interferon response
and inefficient retrograde axonal transport are barriers of
equivalent strength, and that these barriers reduce pathogenicity
by limiting viral trafficking to the CNS.
Discussion
Paralytic poliomyelitis due to viral CNS invasion and motor
neuron destruction is very rare, occurring in less than 1% of
unvaccinated individuals. A variety of hypotheses have been
proposed to explain the rare poliovirus CNS invasion, ranging
from fatigue to recent injury [21,24,25]. In this work, we identified
three major barriers that may contribute to the rare incidence of
paralytic poliomyelitis by limiting poliovirus trafficking from the
periphery to the CNS: inefficient retrograde axonal transport,
limited viral replication in the PNS, and the interferon response.
Type I interferon has been shown to reduce replication of many
viruses, and to limit the pathogenicity of neurotropic viruses
[9,26,27,28,29,30]. Perhaps predictably, we demonstrated that the
type I interferon response can limit poliovirus dissemination by
limiting replication in peripheral tissues, such as muscle.
Surprisingly, we identified inefficient retrograde axonal transport
asa majorbarrier limiting poliovirustraffickinginPNS neuronsand
viral access to the CNS. In peripheral neurons, retrograde axonal
transport of poliovirus and other viruses is very fast [1,12,31], and
transport can be increased by muscle injury [14,21]. While retro-
grade axonal transport may be fast, we demonstrate here that it is
very inefficient for poliovirus, with only 28% of viral pool members
Figure 6. The effect of barriers on viral pathogenesis. PVR or
PVR-IFNAR
2/2 mice were intramuscularly inoculated with 2610
7 PFU of
the 10-marked viruses, and were treated with or without needle sticks
twice per day. Mice were euthanized upon disease onset; therefore,
results are depicted as percent of mice without symptoms. Untreated
PVR mice, solid black line with circles; PVR mice with needle sticks,
dashed black line with squares; PVR-IFNAR
2/2 mice, solid grey line with
inverted triangle; PVR-IFNAR
2/2 mice given needle sticks, grey dashed
line with triangles. Data represent 12–36 mice per condition. Statistically
significant differences between groups are indicated by asterisks
(Mantel-Cox test, p,0.0001).
doi:10.1371/journal.ppat.1000791.g006
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retrograde axonal transport of poliovirus can be thought of as a fast
roller coaster without seatbelts, resulting in loss of passengers during
theride.Thesciaticnerveconsists ofcellsupto5 cmlong;therefore,
active transport is required for viral trafficking. Although transport
is inefficient, uptake of poliovirus at the neuromuscular junction is
efficient, because 87% of pool members present in muscle were
present in lower sciatic nerve. The inverse has been observed for
neurotrophins, a class of host proteins that are transported by
retrograde axonal transport [32,33,34,35]. For neurotrophins,
retrograde axonal transportis thought to be efficient and processive;
however, neurotrophin cellular entry at the neuromuscular junc-
tion is quite inefficient [23,36,37]. Therefore, either viral transit
mechanisms are not completely conserved with host transit
mechanisms, or there are multiple host pathways that differ in
retrograde axonal transport processivity [11]. It is also possible that
poliovirus overwhelms the transport system or is degraded during
retrograde axonal transport, thus explaining inefficient transport
despite efficient uptake at the neuromuscular junction. Alternative-
ly, retrograde axonal transport of host cargo may be as inefficient as
poliovirus transport.
While retrograde axonal transport of poliovirus in peripheral
neurons was inefficient, the efficiency increased upon muscle
damage. Gromeier and Wimmer suggested that muscle damage
enhances poliovirus CNS access and contributes to some cases of
paralytic poliomyelitis [14,21], and nerve injury is known to
increase retrograde axonal transport of neurotrophins [38].
Additionally, muscle injury induces inflammation, which may
also impact viral trafficking. Provocation poliomyelitis occurs
when physical trauma near the time of poliovirus infection
coincides with increased incidence of paralytic poliomyelitis. This
effect was observed during the Cutter incident, where batches of
incompletely inactivated poliovirus vaccine caused paralysis
preferentially in the inoculated limb [39,40]. Additional cases of
paralytic poliomyelitis occurred when the attenuated oral polio
vaccine was administered near the time of multiple unrelated
intramuscular injections [41]. Our data demonstrating that muscle
damage increases the efficiency of retrograde axonal transport
may provide the mechanism for the increased incidence of
paralytic poliomyelitis following muscle damage.
Several viruses traffic in PNS neurons to reach the CNS. For
example, reovirus can traffic to the CNS via the vagus and sciatic
nerves, and alpha herpesviruses traffic to the CNS in PNS neurons
[42,43,44,45,46]. Our results suggest that after oral infection,
poliovirus may traffic through PNS neurons to the CNS because
orally inoculated poliovirus was detected in peripheral neurons
(vagus and sciatic). We also found that the viral pool members
present in sciatic and vagus nerves were highly bottlenecked, and
matched brain virus 63% of the time (Figure S1 and data not
shown), suggesting that transport of virus from PNS neurons to the
CNS may occur after natural oral infection.
In addition to inefficient retrograde axonal transport in neurons,
we found that poliovirus replication was limited in peripheral
neurons. Using light sensitive viruses, we found no evidence of
viral replication in the sciatic nerve despite robust replication in
the CNS. These results are supported by data from Ohka et al.,
showing intact 160S virions in sciatic nerve [12]. Perhaps it is not
surprising that viral replication is limited in peripheral neurons,
since substrates required for viral replication are likely to be
limited in long axons, and viruses may reside in endosomes during
the entire axon transport period. Nonetheless, if virions or virion-
containing endosomes disassociate from the retrograde axonal
transport machinery, viral replication may be impossible within
the axon.
Taken together, our results support the neural route as a major
pathway of poliovirus trafficking to the CNS in mice; however,
trafficking in neurons is difficult due to inefficient retrograde
axonal transport. We propose that PNS barriers contribute to the
low incidence of paralytic poliomyelitis in humans, and may
contribute to inefficient trafficking of other neurotropic viruses.
Materials and Methods
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the UT
Southwestern Medical Center IACUC.
Viruses and Cells
Virulent Mahoney type 1 poliovirus was propagated and titered
in HeLa cells as previously described [16,47]. The ten marked
viruses for the viral diversity assay each contain groups of 4–8
silent point mutations that allow specific probe annealing following
RT-PCR and dot blotting (see Figure S1 and [16] for more
details). These viruses exhibit no detectable fitness differences [16].
Light sensitive poliovirus was prepared and analyzed as previously
described [16,18,19,20]. Briefly, HeLa cells were infected with
each marked virus in the presence of 10 mg/ml neutral red dye.
Work with neutral red viruses was preformed in the dark, using a
red photography light. Inactivation of neutral red viruses was
achieved by exposure to a fluorescent light for 10 min. Samples
were processed in the dark and supernatant from each tissue was
divided in half (half was then exposed to light and the other half
was always kept in the dark). For titer analysis, the ratio of PFU in
light exposed versus non-light exposed samples were compared to
determine the percent replicated virus [16]. The ratio of light-
insensitive to light-sensitive PFU in the neutral red poliovirus stock
was 1 to 1,270,000 [16]. Based on previous work and this study,
we routinely detect 100% of in vitro and in vivo replicated viruses
using this assay (data not shown) [16].
Mouse Experiments
C57/BL6 mice expressing the human poliovirus receptor
(CD155/PVR, called PVR) and C57/BL6 PVR mice deficient
in the interferon-a/b receptor (called PVR-IFNAR
2/2 mice) were
a generous gift from S.Koike (Tokyo, Japan) [7,29]. Oral
inoculations were performed by pipetting 2610
7 total PFU of an
equal mixture of all 10 viruses in 15 ml volume into the mouth
[16]. Inoculum was prepared by mixing 2610
6 PFU of each virus
per mouse (according to viral titer assay), and a large cocktail was
prepared for each experiment such that all animals received the
same mixture. For intramuscular injections, 2610
6 PFU of each
marked virus (2610
7 total PFU in 50 ml) was injected into the
lower left gastrocnemius muscle [16]. Needle sticks were given by
inserting a 28-gauge needle into the leg 4 or 5 times twice daily
[21]. For all poliovirus experiments, mice were monitored twice a
day (at ,10–14 hour intervals) and euthanized at the first sign of
disease, which is typically paralysis of one hind limb. Upon onset
of symptoms, mice fail to recover and typically succumb to disease
within 12 hours (data not shown). Therefore, time of disease onset
correlates with time of death, and can be used as a more humane
alternative to death as an endpoint.
Tissue Harvest and Processing
Whole sciatic nerve was removed by lifting the biceps femoris
and removing the nerve segment between the spine and ankle.
The nerve was then sectioned into three equal pieces to generate
Neurotropic Virus CNS Barriers
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removed as a segment from the heart-lung junction to the
diaphragm. Muscle included all non-bone tissue below the hip.
Tissues (whole spine, brain, stomach, small intestine, colon) were
weighed and resuspended in three volumes PBS+ (16 PBS with
100 mg/ml MgCl2 and CaCl2), and homogenized in liquid
nitrogen with a mortar and pestle [17] or with a Bullet Blender
tissue homogenizer (Next Advanced Inc, Averill Park, NY) as per
manufacturers instructions, followed by freeze-thawing three times
to release virus and chloroform extraction of gut samples to
inactivate bacteria [16]. Vagus and sciatic nerve tissue were
dounce homogenized. All samples and tissues were stored at
280uC.
Hybridization-Based Viral Population Diversity Assay
Detection of the 10 marked polioviruses was performed as
previously described [16]. Briefly, viruses from homogenized
tissues with low viral titers (stomach, colon, small intestine, vagus,
and sciatic nerve) were amplified in HeLa cells, followed by
TRIZOL (Invitrogen, Carlsbad, CA) extraction of RNA. Tissues
with high viral titers (brain, spine, muscle) were directly extracted
with TRIZOL because there was no difference between results
from amplifying viruses in HeLa cells and direct TRIZOL
extraction of high titer tissues (data not shown). RT-PCR for the
tagged region of the virus was performed as previously described
[16]. After blotting equivalent concentrations of PCR products on
Hybond N+ membranes (GE Healthcare, Buckinghamshire, UK)
individual membranes were pre-hybridized and hybridized at
59uC. Primers specific for each of the 10 viruses were kinased with
[c-
32P]ATP to serve as probes [16]. Following hybridization,
membranes were exposed to PhosphorImager screens and specific
signal was determined by normalizing blots to perfectly matched
and mismatched control PCR product dots and image intensity
was uniformly adjusted until mismatched sample was no longer
visible in order to eliminate low low-level cross reactive signal (see
[16] for more details). For the neutral red diversity assay in
Figure 4, signal from light exposed samples was compared to signal
from non-light exposed samples from the same tissue. Any viral
pool members present only in the dark sample were scored as
‘non-replicated’ virus, and viral pool members present in both the
dark and the light sample were scored as ‘replicated+non-
replicated’ (see Figure 4 for more details).
Wheat Germ Agglutinin Experiments
Tissues were collected from mice 6 hours after injecting 5 mg
WGA into the lower gastrocnemius muscle. Muscle was weighed
and resuspended in 2 volumes of RIPA buffer (10 mM
Tris,150 mM NaCl, 0.02% NaN3, 1% Na-deoxycholate, 1%
Triton X-100, 0.1% SDS) and sciatic nerve was resuspended in
200 ml of RIPA buffer. Samples were then homogenized with the
Bullet Blender, and 10 ml/ml of a protease inhibitor cocktail
(Sigma, St Louis, MO) and 10 ml/ml of a phosphatase inhibitor
(Calbiochem, San Diego, CA) were added to the supernatants. Dot
blot westerns were performed in place of typical gel-based westerns
due to multimerization of WGA; therefore, five microliters of each
sample was pipetted directly onto a nitrocellulose membrane (GE
Water & Process Technologies), which was probed with rabbit
anti-lectin (triticum vulgaris) primary antibody (Sigma, St Louis,
MO) and goat anti-rabbit HRP secondary antibody. Signal was
visualized with ECL reagent (GE Healthcare, Buckinghamshire,
UK) and quantified by densitometry [48]. Specific WGA signal
was distinguished from background by normalizing to a sciatic
nerve sample that was not exposed to WGA. WGA signal was
within the linear range of detection based on loading and
quantification of purified WGA dilutions (data not shown).
Supporting Information
Figure S1 Artificial quasispecies system and poliovirus popula-
tion dynamics following oral inoculation of PVR-IFNAR
2/2
mice. (A) Sequences of marked viruses, showing silent mutations
(bold underline) in the poliovirus genome. (B) A representative blot
from an orally inoculated PVR-IFNAR
2/2 mouse, and (C) results
from all orally inoculated PVR-IFNAR
2/2 mice. Mice were orally
inoculated with 2610
7 PFU of the 10-marked viruses, and tissues
were harvested upon disease onset. Horizontal lines represent
mean diversity for each tissue.
Found at: doi:10.1371/journal.ppat.1000791.s001 (2.37 MB TIF)
Figure S2 Poliovirus population diversity in tissues from
intramuscularly injected PVR mice. PVR mice were intramuscu-
larly injected with 2610
7 PFU of the 10-virus mixture, and tissues
were harvested at an early time point, 30 hours post-infection
(hpi), or a late time point, 72 hpi (near the time of disease onset).
Viral population diversity was determined by the hybridization
assay, and results from 3-8 mice per group are shown with SEM.
Found at: doi:10.1371/journal.ppat.1000791.s002 (1.63 MB TIF)
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